Our services

Inherited cancer risk

Cancer in the family can cause great and sometimes unnecessary concern. From saliva or blood samples, iCellate can analyze the DNA, assess the inherited risk for cancer and suggest actions to take.

Genetic cancer evaluation

iCellate’s genetic cancer evaluation, using circulating tumor DNA (ctDNA), provides detailed genetic tumor information which may reveal targeted treatment options.

Personal cancer screening

Early detection is important for effective cancer treatment. iCellate can, even before symptoms occur, detect the spreading cancer cells through a simple blood test.

Inherited cancer risk

Those of you who have relatives affected by cancer may want to consider assessing your own risk of developing cancer. One third of the population is directly affected by cancer, and 5-10% of all cancers are hereditary. Understanding your hereditary risk can help you take preventative action. Hereditary risk can be determined through a genetic test, like GeneMate®. GeneMate® analyzes so-called germline DNA (gDNA) that contains information about your hereditary risk.

GeneMate® sample collection occurs on your terms, in your home. A sample collection kit is delivered straight to your mailbox with instructions and materials for saliva collection, as well as everything you need to return the sample to iCellate's lab. iCellate performs a comprehensive analysis and breaks down complex information, ultimately providing you with a concrete risk assessment. iCellate's clinical team is available for consultation along the way.

 

KEEP ME IN THE LOOP

TECHNICAL SPECIFICATION

Services include:
- Saliva DNA collection kit
- Genetic analysis of 29 genes
- Clinical report with cancer risk results
- Support from our licensed genetic counselors along the way

Genetic cancer evaluation

A genetic cancer evaluation is for those who have already been diagnosed with cancer. The public healthcare system follows established guidelines, while private alternatives may offer cutting edge technology early. iCellate has developed new methods, which likely will become standard of care in a few years.

A blood sample can show presence of tumor fragments (called ctDNA). The DNA fragments can be analyzed (sequenced). The resulting list of genetic defects presented in a clinical report may suggest individualized treatment options.

It is important that you as a patient and your doctor agree on which tests that will provide the desired information.
iCellate's expert is always available if you have a specific question about the test or the report.

 

KEEP ME IN THE LOOP

Services include:
- Blood collection kit
- Genetic analysis of 36 genes*
- Clinical report with actionable results

Personal cancer screening

There is not yet a universal cancer-test in the public healthcare system for finding cancer early, i.e. screening. The tests that are available, such as mammography (for breast cancer) and PSA (for prostate cancer), are only focused on one type of cancer and the benefit is therefore limited.

iCellate has demonstrated through two major scientific studies (see here) that our technology serves well as a screening tool.

If you choose to take iCellate’s  Personal cancer screening test, you should familiarize yourself with the implications. What does a positive test result (with traces of cancer in the blood) mean for you? Read more under the FAQs.

 

KEEP ME IN THE LOOP

Services include:
- Referral to blood draw
- CTC detection
- Genetic analys of 22 genes
- Clinical report